logo
AAT Bioquest

Protonex™ Green 500 PEG12 maleimide

The pH-dependent emission spectra of Protonex™ Green 500-PEG12.
The pH-dependent emission spectra of Protonex™ Green 500-PEG12.
The pH-dependent emission spectra of Protonex™ Green 500-PEG12.
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
Molecular weight1164.32
SolventDMSO
Spectral properties
Excitation (nm)453
Emission (nm)522
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC12352200

OverviewpdfSDSpdfProtocol


Molecular weight
1164.32
Excitation (nm)
453
Emission (nm)
522
Protonex™ Green 500 PEG12 maleimide is a thiol-reactive, pH-sensitive fluorophore specifically designed for developing pH-responsive bioconjugates to investigate processes such as antibody internalization, endocytosis, and phagocytosis in live cells. The incorporation of a polyethylene glycol (PEG12) spacer arm significantly enhances the aqueous solubility of the dye, thereby reducing the potential for bioconjugate aggregation without compromising its biological functionality. As the pH shifts from basic to acidic, Protonex™ Green 500 PEG12 exhibits increased fluorescence, which aligns with the acidification of intracellular vesicles. The increase in fluorescence as the pH transitions from neutral to acidic obviates the need for extensive washing steps due to its lack of fluorescence in typical extracellular environments. Protonex™ Green 500 PEG12 maleimide is particularly effective in monitoring acidic cellular compartments, such as phagosomes, endosomes, and lysosomes, where it exhibits significantly enhanced fluorescence, providing precise detection of these acidic sites. This characteristic facilitates the specific detection of cellular acidic compartments with reduced signal variability and improved accuracy for applications in imaging, flow cytometry, and high-content screening (HCS). The maleimide functionality allows for specific conjugation to free sulfhydryl groups from reduced cysteines in proteins or peptides, oligonucleotide thiophosphates, or small molecular ligands. Such bioconjugates are crucial for targeted detection and analysis of cellular processes like phagocytosis and endocytosis, and support comprehensive multiplexed analyses of cellular functions, enabling detailed investigations into cellular dynamics.

Example protocol


PREPARATION OF STOCK SOLUTIONS

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles

Protein stock solution (Solution A)
  1. Mix 100 µL of a reaction buffer (e.g., 1 M  sodium carbonate solution or 1 M phosphate buffer with pH ~9.0) with 900 µL of the target protein solution (e.g., antibody, protein concentration >2 mg/mL if possible) to give a 1 mL protein labeling stock solution.

    Note: The pH of the protein solution (Solution A) should be 8.5 ± 0.5. If the pH of the protein solution is lower than 8.0, adjust the pH to the range of 8.0-9.0 using 1 M  sodium bicarbonate solution or 1 M pH 9.0 phosphate buffer.

    Note: The protein should be dissolved in 1X phosphate-buffered saline (PBS), pH 7.2-7.4. If the protein is dissolved in Tris or glycine buffer, it must be dialyzed against 1X PBS, pH 7.2-7.4, to remove free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) that are widely used for protein precipitation.

    Note: Impure antibodies or antibodies stabilized with bovine serum albumin (BSA) or gelatin will not be labeled well. The presence of sodium azide or thimerosal might also interfere with the conjugation reaction. Sodium azide or thimerosal can be removed by dialysis or spin column for optimal labeling results.

    Note: The conjugation efficiency is significantly reduced if the protein concentration is less than 2 mg/mL. For optimal labeling efficiency, the final protein concentration range of 2-10 mg/mL is recommended.

Optional: Disulfide Reduction

If your protein does not contain a free cysteine, you must treat your protein with DTT or TCEP to generate a thiol group. DTT or TCEP converts disulfide bonds to two free thiol groups. If you use DTT, you must remove free DTT by dialysis or gel filtration before conjugating the Protonex™ Green 500 PEG12 maleimide to your protein. The following is a sample protocol for generating a free thiol group:

  1. Prepare a fresh solution of 1 M DTT (15.4 mg/100 µL) in distilled water.

  2. To make an IgG solution in 20 mM DTT, add 20 µL of DTT solution per 1 mL of IgG solution while mixing well. Allow the solution to stand at room temperature for 30 minutes without additional mixing to reduce the oxidation of cysteines to cystines. 

  3. Pass the reduced IgG through the filtration column that has been pre-equilibrated with "Exchange Buffer." Collect 0.25 mL fractions from the column.

  4. Determine the protein concentrations and pool the fractions with the majority of the IgG. This can be done either spectrophotometrically or colorimetrically.

  5. It is recommended to carry out the conjugation immediately after this step. Please refer to the Sample Experiment Protocol for more details.

    Note: IgG solutions should be >4 mg/mL for the best results. The protein should be concentrated if less than 2 mg/mL. An additional 10% should be included for losses on the buffer exchange column.

    Note: The reduction can be carried out in almost any buffers from pH 7-7.5 (e.g., MES, phosphate, or TRIS buffers).

    Note: Steps 3 and 4 can be replaced by dialysis.

Protonex™ Green 500 PEG12 maleimide stock solution (Solution B)
  1. Add anhydrous DMSO into the vial of Protonex™ Green 500 PEG12 maleimide to make a 10 mM stock solution. Mix well by pipetting or vortex.

    Note: Prepare the dye stock solution (Solution B) before starting the conjugation. Use promptly. Extended storage of the dye stock solution may reduce the dye activity. Solution B can be stored in the freezer for two weeks when kept from light and moisture. Avoid freeze-thaw cycles.

SAMPLE EXPERIMENTAL PROTOCOL

Important

This protocol was developed for conjugating Protonex™ Green 500 PEG12 maleimide to goat anti-mouse IgG. Additional optimization may be necessary for your specific protein.

Note: Each protein requires a distinct dye/protein ratio, which also depends on the properties of dyes. Over-labeling of a protein could detrimentally affect its binding affinity, while the protein conjugates of low dye/protein ratio give reduced sensitivity.

Run Conjugation Reaction
  1. Use a 10:1 molar ratio of Solution B (dye)/Solution A (protein) as the starting point:  Add 5 µL of the dye stock solution (Solution B, assuming the dye stock solution is 10 mM) into the vial of the protein solution (95 µL of Solution A) with effective shaking. The concentration of the protein is ~0.05 mM assuming the protein concentration is 10 mg/mL and the molecular weight of the protein is ~200 KD.

    Note: We recommend using a 10:1 molar ratio of Solution B (dye)/Solution A (protein). If it is too low or too high, determine the optimal dye/protein ratio at 5:1, 15:1, and 20:1, respectively.

  2. Continue to rotate or shake the reaction mixture at room temperature for 30-60 minutes. 

Purify the Conjugation

The following protocol is an example of dye-protein conjugate purification by using a Sephadex G-25 column.

  1. Prepare the Sephadex G-25 column according to the manufacturer's instructions.

  2. Load the reaction mixture (From "Run conjugation reaction") to the top of the Sephadex G-25 column.

  3. Add PBS (pH 7.2-7.4) as soon as the sample runs just below the top resin surface.

  4. Add more PBS (pH 7.2-7.4) to the desired sample to complete the column purification. Combine the fractions that contain the desired dye-protein conjugate.

    Note: For immediate use, the dye-protein conjugate needs to be diluted with staining buffer, and aliquoted for multiple uses.

    Note: For longer-term storage, the dye-protein conjugate solution needs to be concentrated or freeze-dried.

Characterize the Desired Dye-Protein Conjugate

The Degree of Substitution (DOS) is the most important factor for characterizing dye-labeled protein. Proteins of lower DOS usually have weaker fluorescence intensity, but proteins of higher DOS (e.g. DOS > 6) tend to have reduced fluorescence too. The optimal DOS for most antibodies is recommended between 2 and 10 depending on the properties of dye and protein. For effective labeling, the degree of substitution should be controlled to have 6-8 moles of Protonex™ Green 500 PEG12 maleimide to one mole of antibody. The following steps are used to determine the DOS of Protonex™ Green 500 PEG12 maleimide labeled proteins.

Measure absorption

To measure the absorption spectrum of a dye-protein conjugate, it is recommended to keep the sample concentration in the range of 1-10 µM depending on the extinction coefficient of the dye.

Read OD (absorbance) at 280 nm and dye maximum absorption (ƛmax = 522 nm for Protonex™ Green 500 PEG12 maleimide dyes)

For most spectrophotometers, the sample (from the column fractions) needs to be diluted with de-ionized water so that the OD values are in the range of 0.1 to 0.9. The O.D. (absorbance) at 280 nm is the maximum absorption of protein while 522 nm is the maximum absorption of Protonex™ Green 500 PEG12 maleimide. To obtain accurate DOS, make sure that the conjugate is free of the non-conjugated dye.

Calculate DOS

You can calculate DOS using our tool by following this link:

https://www.aatbio.com/tools/degree-of-labeling-calculator  

Calculators


Common stock solution preparation

Table 1. Volume of DMSO needed to reconstitute specific mass of Protonex™ Green 500 PEG12 maleimide to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

0.1 mg0.5 mg1 mg5 mg10 mg
1 mM85.887 µL429.435 µL858.87 µL4.294 mL8.589 mL
5 mM17.177 µL85.887 µL171.774 µL858.87 µL1.718 mL
10 mM8.589 µL42.944 µL85.887 µL429.435 µL858.87 µL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)Molecular weightVolume (Calculate)Concentration (Calculate)Moles
/=x=

Spectrum


Open in Advanced Spectrum Viewer
spectrum

Spectral properties

Excitation (nm)453
Emission (nm)522

Product Family


NameExcitation (nm)Emission (nm)
Protonex™ Green 500-PEG12, SE453522

Images


References


View all 50 references: Citation Explorer
Dissecting the roles of dynamin and clathrin in platelet pinocytosis.
Authors: Baxter, Ruby M and Harper, Matthew T
Journal: Biochemical and biophysical research communications (2024): 150250
Flagellar pH homeostasis mediated by Na+/H+ exchangers regulates human sperm functions through coupling with CatSper and KSper activation.
Authors: Liang, Min and Ji, Nanxi and Song, Jian and Kang, Hang and Zeng, Xuhui
Journal: Human reproduction (Oxford, England) (2024): 674-688
Quantification of Microglial Engulfment of Synaptic Material Using Flow Cytometry.
Authors: Ugursu, Bilge and Wolf, Susanne A
Journal: Journal of visualized experiments : JoVE (2024)
ClinOleic Impairs ROS Production and Phagocytosis in M1 Macrophages Without Affecting M1 Differentiation.
Authors: Tsai, Yi-Sheng and Yeh, Hsuan-Te and Chen, Ming-Shan and Chang, Hui-Ju and Lin, Wen-Chun and Sheu, Shew-Meei
Journal: Cell biochemistry and biophysics (2024)
Disease activity is associated with changes in the innate immune function in patients with systemic lupus erythematosus.
Authors: Torres-Ruiz, Jiram and Rull-Gabayet, Marina and Mejía-Domínguez, Nancy R and Carrillo-Vázquez, Daniel Alberto and Reyes-Islas, Juan Alberto and Cassiano-Quezada, Fabiola and Cuellar-Rodríguez, Jennifer and Sierra-Madero, Juan and Sánchez, Jessica Márquez and Serrano-García, Jesús Salvador and González, Alexia Esquinca and Juárez-Vega, Guillermo and Tapia-Rodríguez, Miguel and Gómez-Martín, Diana
Journal: Clinical rheumatology (2024): 501-509
Phylogenomic, structural, and cell biological analyses reveal that Stenotrophomonas maltophilia replicates in acidified Rab7A-positive vacuoles of Acanthamoeba castellanii.
Authors: Rivera, Javier and Valerdi-Negreros, Julio C and Vázquez-Enciso, Diana M and Argueta-Zepeda, Fulvia-Stefany and Vinuesa, Pablo
Journal: Microbiology spectrum (2024): e0298823
E-cigarette vapor renders neutrophils dysfunctional due to filamentous actin accumulation.
Authors: Jasper, Alice E and Faniyi, Aduragbemi A and Davis, Lauren C and Grudzinska, Frances S and Halston, Robyn and Hazeldine, Jon and Parekh, Dhruv and Sapey, Elizabeth and Thickett, David R and Scott, Aaron
Journal: The Journal of allergy and clinical immunology (2024): 320-329.e8
Janus Kinase Inhibitor Brepocitinib Rescues Myelin Phagocytosis Under Inflammatory Conditions: In Vitro Evidence from Microglia and Macrophage Cell Lines.
Authors: Romero-Ramírez, Lorenzo and García-Rama, Concepción and Mey, Jörg
Journal: Molecular neurobiology (2024)
Increased Neutrophil H2O2 Production and Enhanced Pulmonary Clearance of Klebsiella pneumoniae in G6PD A- Mice.
Authors: Zuchelkowski, Benjamin E and Peñaloza, Hernán F and Xiong, Zeyu and Wang, Ling and Cifuentes-Pagano, Eugenia and Rochon, Elizabeth and Yang, Minying and Gingras, Sebastien and Gladwin, Mark T and Lee, Janet S
Journal: Research square (2024)
MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection.
Authors: De, Mithu and Serpa, Gregory and Zuiker, Eryn and Hisert, Katherine B and Liles, W Conrad and Manicone, Anne M and Hemann, Emily A and Long, Matthew E
Journal: Frontiers in cellular and infection microbiology (2024): 1275940